Skip to content

In this study certain skin and hair care products will be checked for their safety using patch test method.

Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019826
Enrollment
24
Registered
2019-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Johara Anti hair fall serum: 40 µl without dilution will be pipetted out on the allotted Dermaproof aluminium finn chamber prefixed to a scanpore tape and applied for 24hrs. Intervent

Sponsors

Sami Labs Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects in age group 18-65 years both inclusive. 2 Healthy male & female subjects. 3 Subjects with Fitzpatrick skin type III to V. 4 Subjects willing to give a written informed consent. 5 Subjects willing to maintain the patch test in position for 24 hours. 6 Subject having not participated in a similar investigation in the past two weeks. 7 Subjects willing to come for regular follow up visits. 8 Subjects ready to follow instructions during the study period.

Exclusion criteria

Exclusion criteria: 1 Subjects with infection, allergy on the tested area. 2 Subjects with skin allergy, antecedents or atopic subjects. 3 Athletes and subjects with history of excessive sweating. 4 Subjects with any cutaneous disease which may influence the study result. 5 Subjects on oral corticosteroid. 6 Subjects participating in any other cosmetic or therapeutic study. 7 Subject with known allergy or sensitization to medical adhesives, bandages. 8 Subjects who are pregnant or lactating. 9 Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
1] Draize scale for irritation score 2] PhotographsTimepoint: 1] Draize scale for irritation score-Baseline,15 to 30 mins post patch removal,minimum 168 hours post patch removal. 2] Photographs-Baseline and all time points listed above.

Secondary

MeasureTime frame
Safety assessment-Adverse and serious adverse event monitoringTimepoint: Safety assessment-Visit 2,Visit 3,visit 4 and Visit 5.

Countries

India

Contacts

Public ContactDr Renuka Jain

Sami Labs Limited

renuka@samilabs.com08028397973

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026